Department of Urology, Siirt State Hospital, Siirt, Turkey.
Department of Biochemistry, Siirt State Hospital, Siirt, Turkey.
J Med Virol. 2021 Feb;93(2):786-793. doi: 10.1002/jmv.26300. Epub 2020 Jul 22.
We aimed to examine independent predictive factors for the severity and survival of COVID-19 disease, from routine blood parameters, especially the blood urea nitrogen (BUN)/creatinine (Cr) ratio. A total of 139 patients with COVID-19 were investigated at Siirt State Hospital. According to the disease severity, the patients were categorized as three groups (moderate: 85, severe: 54, and critical: 20). Then, patients were divided into two groups: nonsevere (moderate) and severe (severe and critical). Demographic, clinical data, and routine blood parameters were analyzed. In multivariate model adjusted for potential confounders BUN/Cr ratio (odds ratio [OR] = 1.70; 95% confidence interval [CI]: 1.20-2.40; P = .002) and neutrophil to lymphocyte ratio (NLR) (OR = 2.21; 95% CI: 1.20-4.30; P < .001) were independent predictive factors for disease severity. In multivariate Cox proportional hazard model BUN/Cr ratio (hazard ratio [HR] = 1.02; 95% CI: 1.01-1.05; P = .030), and NLR (HR = 1.17; 95% CI: 1.06-1.30; P = .020) were independent predictors for survival of COVID-19 disease. The optimal thresholds of the BUN/Cr ratio at 33.5 and 51.7 had the superior possibility for severe disease and mortality, area under the curve (AUC) were 0.98 and 0.95, respectively. The optimal thresholds of NLR at 3.27 and 5.72 had a superior possibility for severe disease and mortality, AUC were 0.87 and 0.85, respectively. BUN/Cr and NLR are independent predictors for COVID-19 patient severity and survival. Routine evaluation of BUN/Cr and NLR can help identify high-risk cases with COVID-19.
我们旨在从常规血液参数中,尤其是血尿素氮(BUN)/肌酐(Cr)比值,研究 COVID-19 疾病严重程度和生存的独立预测因素。共对锡尔特州立医院的 139 例 COVID-19 患者进行了调查。根据疾病严重程度,将患者分为三组(中度:85 例,重度:54 例,危重症:20 例)。然后,将患者分为两组:非重症(中度)和重症(重度和危重症)。分析了人口统计学、临床数据和常规血液参数。在调整了潜在混杂因素的多变量模型中,BUN/Cr 比值(优势比[OR] = 1.70;95%置信区间[CI]:1.20-2.40;P = .002)和中性粒细胞与淋巴细胞比值(NLR)(OR = 2.21;95%CI:1.20-4.30;P < .001)是疾病严重程度的独立预测因素。在多变量 Cox 比例风险模型中,BUN/Cr 比值(风险比[HR] = 1.02;95%CI:1.01-1.05;P = .030)和 NLR(HR = 1.17;95%CI:1.06-1.30;P = .020)是 COVID-19 疾病生存的独立预测因子。BUN/Cr 比值的最佳截断值为 33.5 和 51.7,对严重疾病和死亡率的可能性较大,曲线下面积(AUC)分别为 0.98 和 0.95。NLR 的最佳截断值为 3.27 和 5.72,对严重疾病和死亡率的可能性较大,AUC 分别为 0.87 和 0.85。BUN/Cr 和 NLR 是 COVID-19 患者严重程度和生存的独立预测因子。常规评估 BUN/Cr 和 NLR 有助于识别 COVID-19 的高危病例。
Biosensors (Basel). 2025-6-25
Cell Rep Methods. 2025-4-21
Front Med (Lausanne). 2025-3-26
J Med Virol. 2021-1
Clin Chim Acta. 2020-4-24
Int Immunopharmacol. 2020-4-13
Kidney Int. 2020-3-20
Clin Infect Dis. 2020-7-28
Lancet Respir Med. 2020-4
N Engl J Med. 2020-1-29